SCHEMBL6581665

SCHEMBL6581665

Cc1c(O)noc1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.44
ALDH1A1 P00352 5/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PTGS1 P23219 2/20 0.42
DUSP3 P51452 3/20 0.41
KDM4E B2RXH2 2/20 0.41
BRD4 O60885 2/20 0.41
BRD2 P25440 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LPAR1 Q92633 1/20 0.40
LPAR3 Q9UBY5 1/20 0.40
PTGS2 P35354 1/20 0.40
TP53 P04637 2/20 0.39
IP6K1 Q92551 1/20 0.39
IP6K3 Q96PC2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
IP6K2 Q9UHH9 1/20 0.39
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3751072 0.79 BRD4 (0.53) PTPN1ALDH1A1MAPTSMN1; SMN2PTGS1
SCHEMBL21105084 0.78 PTGS1 (0.55) PTPN1ALDH1A1MAPTSMN1; SMN2PTGS1
SCHEMBL15270257 0.77 ESR1 (0.50) ALDH1A1MAPTSMN1; SMN2PTGS1DUSP3
SCHEMBL19916055 0.77 HRH3 (0.42) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL8376901 0.76 PTPN1 (0.44) PTPN1ALDH1A1MAPTSMN1; SMN2PTGS1
SCHEMBL8375545 0.76 MEN1 (0.49) PTPN1ALDH1A1MAPTSMN1; SMN2PTGS1
SCHEMBL7050224 0.76 ALDH1A1 (0.46) PTPN1ALDH1A1MAPTSMN1; SMN2PTGS1
SCHEMBL8375701 0.76 PTPN1 (0.44) PTPN1ALDH1A1MAPTSMN1; SMN2PTGS1
SCHEMBL4076415 0.76 PTPN1 (0.67) PTPN1ALDH1A1MAPTPTGS1DUSP3
SCHEMBL12000499 0.76 PTGS1 (0.43) PTPN1ALDH1A1MAPTSMN1; SMN2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0737680-B1 (Phenylalkylaminoalkyloxyl)-hetero-aryl compounds, processes and intermediates for their preparation and medicaments containing these compounds SOLVAY PHARM GMBH (DE) 2004-03-03 EP disclosed
EP-0737680-A1 (Phenylalkylaminoalkyloxyl)-hetero-aryl compounds, processes and intermediates for their preparation and medicaments containing these compounds Kali-Chemie Pharma GmbH (DE) 1996-10-16 EP disclosed
US-5321037-A Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants SANKYO COMPANY, LIMITED (JP) 1994-06-14 US disclosed
EP-0335723-B1 ISOXAZOLE DERIVATIVES FOR USE AS CEREBRO-ACTIVE DRUGS AND CENTRAL MUSCLE RELAXANTS Sankyo Company Limited (JP) 1991-12-04 EP disclosed
EP-0335723-A1 Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants Sankyo Company Limited (JP) 1989-10-04 EP disclosed